The Caris Precision Oncology Alliance Welcomes UAMS Winthrop P. Rockefeller Cancer Institute

Core Insights - Caris Life Sciences has announced the addition of the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute to its Caris Precision Oncology Alliance (Caris POA), enhancing its global network focused on precision oncology and biomarker-driven research [1][2][3] Company Overview - Caris Life Sciences is a leading AI TechBio company specializing in precision medicine, utilizing advanced AI and machine learning to develop innovative healthcare solutions [4] - The company has created a large-scale, multimodal clinico-genomic database to analyze the molecular complexity of diseases, aiming to improve early detection, diagnosis, and treatment selection [4] Collaboration Details - The collaboration with UAMS aims to leverage shared data and AI technology to enhance cancer care and research, benefiting patients in Arkansas and globally [2][3] - Caris POA now includes 98 cancer centers and institutions, including 45 NCI-designated cancer centers, all working together to advance precision oncology [3] Research and Development - Members of the Caris POA will utilize Caris' molecular profiling, which encompasses genomic, transcriptomic, and proteomic data, to identify therapeutic options and clinical trial opportunities for patients [3] - The alliance provides access to one of the largest multi-modal databases in the industry, containing extensive matched molecular and clinical outcomes data from hundreds of thousands of cancer patients [3]